Advanced searches left 3/3
Search only database of 8 mil and more summaries

Trump Rem

Summarized by PlexPage
Last Updated: 02 July 2021

* If you want to update the article please login/register

General | Latest Info

On Monday, Department of Health and Human Services announced an agreement to secure large supplies of Drug remdesivir for the United States from Gilead Sciences through September, allowing American hospitals to purchase drugs in amounts allocated by HHS and state Health departments. President Trump has struck an amazing deal to ensure Americans have access to the first authorized therapeutic for COVID-19, said HHS Secretary Alex Azar. To the extent possible, we want to ensure that any American patient WHO needs treatment can get it. The Trump Administration is doing everything in our power to learn more about life-saving therapeutics for COVID-19 and secure access to these options for the American people. HHS has secured more than 500 000 treatment courses for American hospitals through September. This represents 100 percent of Gileads project production for July, 90 percent of production in August, and 90 percent of production in September, in addition to allocation for clinical trials. Treatment course of remdesivir is, on average, 6. 25 vials. Hospitals will receive product shipped by AmerisourceBergen and will pay no more than Gileads Wholesale Acquisition Price, which amounts to approximately 3 200 per treatment course. Generally, patients do not pay directly for Hospital-administer Drugs like remdesivir; rather, for Medicare and most private insurers, drugs cost is incorporated into payments made by insurer, such as Medicare paying for Drugs through diagnostic-relate group. These supplies will be allocated in the same way that Gileads donations of approximately 120 000 treatment courses of remdesivir were allocate: HHS allocates product to state and territorial Health departments based on COVID-19 Hospital burden, and Health departments allocate it to hospitals. Delivery of purchase remdesivir will be streamline, going directly to hospital, per States allocation decision, rather than going first to state Health departments for subsequent delivery to hospitals. Shipments will likely occur every two weeks, as they have with donated product. The final allocation of Gileads approximately 120 000 donated treatment courses is being shipped today, June 29.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

What the law allows

Donald J. Trump for President, Inc., V. Bucks County Board of Elections on Nov. 19, Judge rejected the campaign petition and ordered all 2 177 ballots to be count, dismissing alleged deficiencies as minor. The Judges ' order say, for example, that 1 of 196 ballots being challenged by the Trump campaign contain partial date or no date on the outer envelope. But ballots were submitted in time to be counted since both parties agree in their stipulation of facts that all 1 196 ballots were completed and received between October 7 and November 3 2020, which was the date of election. The Judge also noted that the Trump campaign provided no evidence of fraud. It must be noted that parties specifically stipulate in their comprehensive stipulation of facts that there exists no evidence of any fraud, misconduct, or any impropriety with respect to challenged ballots, Judge Baldi, Republican, write. There is nothing on record and nothing alleged that would lead to the conclusion that any of the challenged ballots were submitted by someone not qualified or entitled to vote in this election. At no time do petitioners present evidence or argument to the contrary. The Trump campaign filed an appeal on Nov. 23 with the Commonwealth Court of Pennsylvania.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

Disappointing trials

It is difficult to draw conclusions about how Trump is doing based on his course of treatment. Gilead, pharmaceutical company that makes Remdesivir, has recommended it for patients with moderate to severe cases of COVID-19, regardless of the need for supplemental oxygen. When FDA issued emergency authorization of drug back on May 1, it did so for patients with severe cases of COVID-19, meaning those with low blood oxygen levels, WHO receive supplemental oxygen or are on a ventilator. In August, FDA said drugs do not need to be limited to only the most severe cases, and on Thursday, FDA renewed emergency authorization of Drug. The drug is still pending formal FDA approval, since clinical trials to evaluate drugs ' effectiveness are still underway. There have been several studies of drug effectiveness for treating COVID-19, assessing how quickly patient shows improvement while on drug compared to receiving placebo. Results so far suggest it can reduce the duration of hospitalization by a few days for severe cases, but there is insufficient evidence on whether it works in mild or moderate cases. When Remdesivir received its first emergency authorization in May, National Institutes Of Health clinical trial had just shown that severe patients recovered in 11 days in the course of its use, compared to 15 days for patients on placebo. Another clinical trial from Gilead showed that the average time to improvement was five days among those with mild and moderate cases of disease, with no difference between those WHO were administered Remdesivir and those receiving placebo. A third study found patients with moderate cases are 65 percent more likely to show improvement over using placebo, when treatment lasts for five days. That difference is erased when treatment lasts for 10 days. According to Health News website STAT, Medical researchers have not been given access to Gileads raw research data to verify these clinical trials. In study published Saturday in peer-review Medical Journal Lancet, authors do not find a significant difference between patients with severe infections WHO use Remdesivir and those on placebo. The authors call these findings disappointing, and say Drug do not appear to lower viral load or mortality. Remdesivirs side effects are still being investigated as well. Gilead notes that serious and unexpected side effects may happen, including allergic reactions and changes to patients ' liver chemistry. The European Union is looking into whether Drug can cause kidney damage in some patients. Overall, Gilead has warned that Remdesivir is still being studied, so it is possible that all of the risks are not known at this time. This therapy is not cheap. Private insurance will be bill 520 per vial, according to Gilead, and 390 per dose for those on some government health programs. For a five-day course of treatment, with double dose on the first day, private insurers as well as Medicare and Medicaid will be charged 3 120.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

Debating the evidence

As he often does, Trump tout fact that he has been nominated for the Nobel Peace Prize, and lament that media coverage he has received for that honor is dwarfed by the press President Barack Obama got in 2009. In Pennsylvania, Trump claim, I got nominated for three Nobel Peace Prizes, but press didnt cover it. Trump made the same claim in Sanford, Florida, adding, Remember when Obama got it right at the beginning. It was the biggest story youve ever see. Trump wasnt nominated for three Nobel Prizes; he was nominated by three people for the same prize. And it is not the big deal Trump makes it out to be. There were 318 candidates for the Nobel Peace Prize for 2020, 211 individuals and 107 organizations. On its website, Nobel Committee warns not to attach too much importance to nomination, saying Any person or Organization can be nominated by anyone eligible to nominate, Committee States. The Norwegian Nobel Committee has NO input into submissions, though it decides WHO actually wins the prize. To simply be nominate is therefore not endorsement or extend honour to imply affiliation with the Nobel Peace Prize or its related institutions, Committee States. Obama got a lot of press in 2009, not for his nomination, which was largely ignored, but for actually winning the prize. Trump did not win it. Trump has claimed repeatedly that, as part of the Iran nuclear deal, US will give Iran 150 billion, 1. 8 billion in cash for nothing. As we have write, nuclear deal with Iran do lift the freeze on Iran's assets that were held largely in foreign, not US, banks. And, to be clear, that money belongs to Iran. Secondly, 150 billion is high-end estimate. The US Treasury Department estimates the number at about 50 billion in usable liquid assets. 1. 8 billion in cash that Trump mentioned is from an unrelated settlement reached by the Obama Administration to resolve a dispute that dates to 1979, when Iran paid US 400 million for military equipment it never receive. The US refused to provide equipment after the Shah of Iran was overthrown in 1979. The US agreed in 2016 to pay 1. 7 billion to settle claim Iran had filed against the US in International tribunal in Hague. Trump repeatedly claims that special counsel Robert Muellers ' investigation into ties between the Trump Campaign and Russia during the 2016 Election was a fake witch hunt, and falsely accused the Obama Administration of spying on our Campaign. As we have write, there was ample evidence to justify opening an investigation, and the Department of Justices Office of Inspector General Report on the origins of the investigation found NO evidence of illegal spying either before or after the FBI opened investigation.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

European Commission in the dark

Lets not panic, say Wolfgang Ischinger, former German ambassador to the United States. The world is not ending, as some people seem to be suggesting. Ischinger organizes the annual Munich Security Conference, world premier gathering for world leaders to discuss issues of war and peace. But he was not referring to worries about nuclear Armageddon, terrorism or even the Coronavirus pandemic. Palpable fear among the European foreign policy elite is about four more years of US President Donald Trump. If Europeans have learnt anything since January 20 2017, it is this: No matter how bad things get with Trump, they can and will get worse. When it comes to Trump, only certainty is sheer destabilizing uncertainty of each and every day. Everyone is concerned about the sort of unpredictability of the White House, Lauri Lepik, longtime Estonian diplomat WHO serves as ambassador to Washington and to NATO, say of the possibility of a second Trump term. Everyone understands he doesnt value transatlantic relations or he values them in a very monetary way. Even those like Ischinger, WHO insist that the world would not end with another Trump term, do not deny that relations between the US and Europe are at historic low. That relationship of fundamental trust, has tended to evaporate a bit over the last three and half years, Ischinger say. Any sense of hope that Europeans might divine from polls showing Trump consistently trailing former Vice President Joe Biden has been offset by a new fear: that the President could lose but contest the results and refuse to leave office. But the simpler possibility, that Trump would come back from his battle with Coronavirus to pull off an upset electoral victory, is awful enough for many European officials. Ties between the US and the EU, already strain, have only frayed further since the President fired his ambassador to the EU, Gordon Sondland, after he testified against the President in his impeachment scandal. Acting ambassador, Ronald Gidwitz, WHO is also US ambassador to Belgium, conceded in an interview that he has had minimal contact with senior EU officials, in part because of Coronavirus and in part because his appointment is temporary. For instance, since his appointment in May, he said he had not spoken to European Commission President Ursula von der Leyen. But Gidwitz warned Europeans WHO might be wishing for Trump to defeat not to underestimate the American President. It is fair to say that all prognosticators say it is going to be a close election, he say. They all count Donald Trump out in 2016, ambassador added with a smile. But yet, here he is.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

Sources

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

logo

Plex.page is an Online Knowledge, where all the summaries are written by a machine. We aim to collect all the knowledge the World Wide Web has to offer.

Partners:
Nvidia inception logo

© All rights reserved
2021 made by Algoritmi Vision Inc.

If you believe that any of the summaries on our website lead to misinformation, don't hesitate to contact us. We will immediately review it and remove the summaries if necessary.

If your domain is listed as one of the sources on any summary, you can consider participating in the "Online Knowledge" program, if you want to proceed, please follow these instructions to apply.
However, if you still want us to remove all links leading to your domain from Plex.page and never use your website as a source, please follow these instructions.